GRP94 (HSP90B1) (676-803) Mouse Monoclonal Antibody [Clone ID: 2H3]
CAT#: AM09037PU-N
Human GRP94/HSP90B1 antibody
Size: 50 ul
Need it in bulk or conjugated?
Get a free quote
CNY 6620.00
货期*
5周
规格
Cited in 1 publication. |
Specifications
Product Data | |
Clone Name | 2H3 |
Applications | ELISA, FACS, ICC/IF, IF, IHC, WB |
Recommend Dilution | ELISA. Western blot. Immunofluorescence (1/100-1/200). Immunohistochemistry on Paraffin Sections (5 µg/ml). |
Reactivity | Human |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Recombinant human TRA1 (676-803aa) purified from E. coli |
Specificity | The antibody recognizes Human TRA1. Other species not tested. |
Isotype | IgG2a, kappa |
Formulation | Liquid in. Phosphate-Buffered Saline (pH 7.4) with 0.02% Sodium Azide, 10% glycerol |
Concentration | 1mg/ml (determined by BCA assay) |
Purification | By protein-G affinity chromatography |
Conjugation | Unconjugated |
Storage Condition | Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80C. Avoid repeated freezing and thawing cycles. |
Gene Name | heat shock protein 90kDa beta family member 1 |
Database Link | |
Background | Tumor rejection antigen 1 (TRA1) is expressed on the surface of human teratocarcinoma stem cells (EC), human embryonic germ cells (EG) and human embryonic stem cells (ES). TRA1 is a marker protein of these stem cells. |
Synonyms | 94 kDa glucose-regulated protein, 94 kDa glucose-regulated protein, HSP90B1, GP96, TRA1, Tumor rejection antigen 1, GRP94, 94 kDa glucose-regulated protein 94 kDa glucose regulated protein, ECGP, Endoplasmin, Endothelial cell (HBMEC) glycoprotein, Glucose regulated protein 94kDa, gp96, gp96 homolog, GRP 9, Heat shock protein 90 kDa beta member 1, Stress inducible tumor rejection antigen GP96, Tumor rejection antigen gp96. |
Reference Data |
Citations (1)
The use of this Antibodies has been cited in the following citations: |
---|
TAS-116, a highly selective inhibitor of heat shock protein 90α and β, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models
,Ohkubo S, Kodama Y, Muraoka H, Hitotsumachi H, Yoshimura C, Kitade M, Hashimoto A, Ito K, Gomori A, Takahashi K, Shibata Y, Kanoh A, Yonekura K,
Mol. Cancer Ther.
,PubMed ID 25416789
[HSP90B1]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
其它HSP90B1产品
Customer
Reviews
Loading...